Loading data
CNDTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.04 bn USD | 3.36 bn USD | 3.72 bn USD | 3.86 bn USD | 4.14 bn USD |
| Cost of revenue | 2.49 bn USD | 2.73 bn USD | 2.89 bn USD | 3.02 bn USD | 3.14 bn USD |
| Research and development expense | 4 m USD | 6 m USD | 7 m USD | 7 m USD | 4 m USD |
| Selling, general and administrative expense | 412 m USD | 455 m USD | 458 m USD | 440 m USD | 544 m USD |
| Interest expense | 48 m USD | 75 m USD | 111 m USD | 84 m USD | 55 m USD |
| Profit before tax | -160 m USD | 504 m USD | -332 m USD | -127 m USD | -25 m USD |
| Income tax expense | 10 m USD | 78 m USD | -36 m USD | 55 m USD | 3 m USD |
| Net income (reported basis) | -170 m USD | 426 m USD | -296 m USD | -182 m USD | -28 m USD |
| Net income attributable to common shareholders | -170 m USD | 426 m USD | -296 m USD | — | — |
| Basic earnings per share | -1.14 USD/share | 2.28 USD/share | -1.41 USD/share | -0.89 USD/share | -0.18 USD/share |
| Diluted earnings per share | -1.14 USD/share | 2.23 USD/share | -1.41 USD/share | -0.89 USD/share | -0.18 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.